Business
Viridian Therapeutics raises USD 350m in convertible notes and equity offerings
Waltham, Massachusetts-based Viridian Therapeutics, Inc. (Nasdaq: VRDN) announced concurrent upsized public offerings totaling USD 350 million in aggregate...
GSK puts up USD 55m for SiranBio's ALK7 siRNA targeting cardiometabolic disease
GSK (NYSE: GSK) has licensed SA030, a Phase I siRNA oligonucleotide targeting activin receptor-like kinase 7 (ALK7), from Suzhou-based SiranBio in a...
Cartography Biosciences secures strategic investment from Samsung Ventures for oncology pipeline
South San Francisco-based Cartography Biosciences has received a strategic equity investment from Samsung Ventures to support the advancement of its...
Kanvas Biosciences closes USD 48m Series A for microbiome cancer immunotherapy
Kanvas Biosciences, a spatial biology company headquartered in Princeton, New Jersey, has closed a USD 48 million Series A to advance its microbiome-based...
LTZ Therapeutics raises USD 38m for myeloid engager immunotherapy pipeline
LTZ Therapeutics, a clinical-stage immunotherapy company headquartered in Redwood City, California, has closed an oversubscribed USD 38 million financing...
CellCentric backed with USD 220m in Series D for myeloma hope inobrodib
Cambridge-based CellCentric has closed an oversubscribed USD 220 million Series D financing round to advance pivotal clinical development of inobrodib, its...
BioOra gains global CAR T-cell therapy rights from Wellington Zhaotai for Atla-cel development
BioOra Limited has signed a binding Heads of Terms agreement with Wellington Zhaotai Therapies Limited granting BioOra exclusive rights to develop and...
Avalo picks up USD 375m via share offering to support IL-1beta development
Wayne, Pennsylvania-based Avalo Therapeutics (Nasdaq: AVTX) announced the pricing of an underwritten public offering totaling USD 375 million in gross...
Abivax raises USD 45m in share offering for royalty repurchase
France-based Abivax SA (Nasdaq/Euronext Paris: ABVX) announced the pricing of a USD 45 million (EUR 38.5 million) offering of American Depositary Shares to...
Signadori Bio closes EUR 11.1m seed extension to advance monocyte engineering platform
Paris-based Signadori Bio SAS has closed a EUR 11.1 million seed extension round to advance its in vivo monocyte engineering platform for solid tumours,...
Bayer to acquire Perfuse Therapeutics for USD 2.45b to expand ophthalmology pipeline with PER-001
Bayer has agreed to acquire South San Francisco-based Perfuse Therapeutics, Inc. for a total potential value of up to USD 2.45 billion, comprising a USD 300...
Scilex spins off ACEA Pharma to Phoenix Asia Holdings in USD 1b all-stock transaction
I need to flag a direct conflict between the two instruction sets provided.
Merck completes USD 2.7b acquisition of Terns Pharmaceuticals for BCR-ABL1 inhibitor TERN-701
Merck (NYSE: MRK) has completed the acquisition of Terns Pharmaceuticals, a US-based clinical-stage biopharmaceutical company, through an all-cash tender...
Pfizer's Q1'26 Earnings Call: Pivotal oncology readouts on track for mid-to-late 2026, Elrexfio meets endpoint
Pfizer held its Q1 2026 earnings conference call on May 5, 2026, with chief scientific officer Chris Boshoff signaling that the Phase III MagnetisMM-5 study...
Cytospire raises GBP 61m via Series A for gamma delta T-cell engagers
Cytospire Therapeutics, a London-based biotech developing multispecific immune cell engager antibodies, has closed an oversubscribed Series A financing...
The AllSci Brief
Systematic R&D and deal news. Daily.